99 related articles for article (PubMed ID: 21353956)
1. Introduction to the CANWARD Study (2007-2009).
Hoban DJ; Zhanel GG
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):289-90. PubMed ID: 21353956
[No Abstract] [Full Text] [Related]
2. Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii.
Garza-González E; Llaca-Díaz JM; Bosques-Padilla FJ; González GM
Chemotherapy; 2010; 56(4):275-9. PubMed ID: 20693798
[TBL] [Abstract][Full Text] [Related]
3. [Survey on the distribution of burn pathogens and their antibiotic resistance in burn unit].
Zhang LQ; Su F; Liu HY; Wu XT; Zhao HT
Zhonghua Shao Shang Za Zhi; 2007 Oct; 23(5):349-51. PubMed ID: 18396761
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
5. Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii.
Wisplinghoff H; Schmitt R; Wöhrmann A; Stefanik D; Seifert H
J Hosp Infect; 2007 Jun; 66(2):174-81. PubMed ID: 17498843
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic comparisons of antimicrobials against nosocomial isolates of escherichia coli, klebsiella pneumoniae, acinetobacter baumannii and pseudomonas aeruginosa from the MYSTIC surveillance program: the OPTAMA Program, South America 2002.
Kiffer CR; Mendes C; Kuti JL; Nicolau DP
Diagn Microbiol Infect Dis; 2004 Jun; 49(2):109-16. PubMed ID: 15183860
[TBL] [Abstract][Full Text] [Related]
7. [Surveillance of multidrug resistant bacteria in a Tunisian hospital].
Thabet L; Messadi Aa; Mbarek M; Turki A; Meddeb B; Ben Redjeb S
Tunis Med; 2008 Nov; 86(11):992-5. PubMed ID: 19213491
[TBL] [Abstract][Full Text] [Related]
8. Temporal changes in bacterial resistance in German intensive care units, 2001-2003: data from the SARI (surveillance of antimicrobial use and antimicrobial resistance in intensive care units) project.
Meyer E; Schwab F; Jonas D; Ruden H; Gastmeier P; Daschner FD
J Hosp Infect; 2005 Aug; 60(4):348-52. PubMed ID: 15923060
[TBL] [Abstract][Full Text] [Related]
9. Criteria of time and antibiotic susceptibility in the elimination of duplicates when calculating resistance frequencies.
Rodríguez JC; Sirvent E; López-Lozano JM; Royo G
J Antimicrob Chemother; 2003 Jul; 52(1):132-4. PubMed ID: 12805258
[TBL] [Abstract][Full Text] [Related]
10. [Bacteriologic profile of bacteremia due to multi-drug resistant bacteria at Charles-Nicolle Hospital of Tunis].
Saïdani M; Boutiba I; Ghozzi R; Kammoun A; Ben Redjeb S
Med Mal Infect; 2006 Mar; 36(3):163-6. PubMed ID: 16458466
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous detection of methicillin-resistant Staphylococcus aureus, Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa by multiplex PCR.
Thong KL; Lai MY; Teh C SJ; Chua KH
Trop Biomed; 2011 Apr; 28(1):21-31. PubMed ID: 21602765
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data.
Lõivukene K; Sepp E; Adamson V; Mitt P; Kallandi U; Otter K; Naaber P
Scand J Infect Dis; 2006; 38(11-12):1001-8. PubMed ID: 17148068
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic resistance in clinical isolates of Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus does not impact sensitivity to human beta defensin 4.
Supp DM; Gardner J; Klingenberg JM; Neely AN
Burns; 2009 Nov; 35(7):949-55. PubMed ID: 19501982
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Staphylococcus aureus isolated in Italy from patients with hospital-acquired infections.
Blandino G; Marchese A; Ardito F; Fadda G; Fontana R; Lo Cascio G; Marchetti F; Schito GC; Nicoletti G
Int J Antimicrob Agents; 2004 Nov; 24(5):515-8. PubMed ID: 15519488
[TBL] [Abstract][Full Text] [Related]
15. [Sensitivity to cefotaxime of bacterial strains isolated at a surgical clinic 1983-1985].
Polaczek-Kornecka B; Dziadur-Goldsztajn Z; Turowski G
Pol Tyg Lek; 1987 Aug 3-10; 42(31-32):979-81. PubMed ID: 3120164
[No Abstract] [Full Text] [Related]
16. [Carbapenem-resistance in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii].
Mischnik A; Kaase M; Lübbert C; Seifert H; Kern WV
Dtsch Med Wochenschr; 2015 Feb; 140(3):172-6. PubMed ID: 25658402
[No Abstract] [Full Text] [Related]
17. [Distribution and drug resistance analysis of bacteria in different wound infections].
Wang Z; Rong XZ; Zhang T; Liu LZ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):82-3, 89. PubMed ID: 19218119
[TBL] [Abstract][Full Text] [Related]
18. Advances in the management of pneumonia in the intensive care unit: review of current thinking.
Rello J; Diaz E; Rodríguez A
Clin Microbiol Infect; 2005 Oct; 11 Suppl 5():30-8. PubMed ID: 16138817
[TBL] [Abstract][Full Text] [Related]
19. Microbiology and drug resistance mechanisms of fully resistant pathogens.
Walsh FM; Amyes SG
Curr Opin Microbiol; 2004 Oct; 7(5):439-44. PubMed ID: 15451497
[TBL] [Abstract][Full Text] [Related]
20. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
